FLNA

Filana Therapeutics Inc. Common Stock (FLNA)

Stock · NASDAQ · Health Care

$0.93as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Resistance level
$1.19
Industry
Biotechnology: Pharmaceutical Preparations

Filana Therapeutics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • FLNA
    Filana Therapeutics Inc. Common Stock
    $0.93
    ▲ 1.09%
    Market cap $49.76MP/E
  • SCYX
    SCYNEXIS Inc. Common Stock
    $5.44
    ▼ 1.45%
    Market cap $50.35MP/E
    $3.53$10.48
  • MREO
    Mereo BioPharma Group plc American Depositary Shares
    $0.2545
    ▼ 6.43%
    Market cap $48.95MP/E
    $0.2$2.37
  • IBO
    Impact BioMedical Inc. Common Stock
    $0.444
    ▲ 0.68%
    Market cap $48.61MP/E 0.52
    $0.37$0.83
  • RNXT
    RenovoRx Inc. Common Stock
    $1.68
    ▲ 13.18%
    Market cap $47.81MP/E
    $0.7006$1.56
  • TCRT
    Alaunos Therapeutics Inc. Common Stock
    $1.56
    ▼ 6.02%
    Market cap $46.52MP/E
    $1.62$4.59
  • RADX
    Radiopharm Theranostics Limited American Depositary Shares
    $2.41
    ▲ 6.64%
    Market cap $44.71MP/E
    $0.009$0.04

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
14.11M
Total value held
$22.94M
Institutional holders
97
Top holders this quarter
  • Unknown2.01M
  • Unknown1.99M
  • Unknown1.93M
  • Unknown1.41M
  • Unknown749.2K
  • Unknown596.2K
  • Unknown559.2K
  • Unknown450.1K
  • Unknown328.6K
  • Unknown326.8K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.